Feedback / Questions
agomelatine (ALTO-300) - Alto Neurosci
https://www.businesswire.com/news/home/20250219461532/en/Alto-Neuroscience-Announces-U.S.-Patent-Granted-Covering-ALTO-300-as-a-Treatment-for-Patients-with-Major-Depressive-Disorder-Characterized-by-an-Electroencephalogram-Biomarker
Feb 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next